ReviewMaterials (Basel, Switzerland)2025
Enhancing the Performance of FFF-Printed Parts: A Review of Reinforcement and Modification Strategies for Thermoplastic Polymers.
Review in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Functional Materials for Additive Manufacturing: Materials Design, Processing, and Emerging Applications.Nanomaterials (Basel, Switzerland) · 2026Review
- Learning Moisture-Induced Damage From Vision: Diffusion Models for Real-Time Monitoring of Additive Manufacturing Processes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Overcoming Impediments to the Qualification of Additively Manufactured Polymer Components: The Case of ULTEM.Polymers · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The technology of 3D printing has become one of the most effective methods of creating various parts, such as those used for fast prototyping. The most important aspect of 3D printing is the selection and application of the appropriate material, also known as filament. The current review concerns mainly the description of the mechanical and physical properties of the different filaments and the possibilities of improving those properties. The review begins with a short description of the development of 3D printing technology. Next, the basic characteristics of thermoplastics used in the fused filament fabrication (FFF) are discussed, namely polylactic acid (PLA), acrylonitrile butadiene styrene (ABS), and polyethylene terephthalate glycol (PETG). According to modern concepts, the printed parts can be reinforced with the use of different kinds of fibers, namely synthetic fibers (carbon, glass, aramid) or natural fibers (wood, flax, hemp, jute). Thus, the impact of such a reinforcement on the performance of FFF composites is also presented. The current review, unlike other works, primarily addresses the problem of the aging of parts made from the thermoplastics above. Environmental conditions, including UV radiation, can drastically reduce the physical and mechanical properties of printed elements. Moreover, the current review contains a detailed discussion about the influence of the different fibers on the final mechanical properties of the printed elements. Generally, the synthetic fibers improve the mechanical performance, with documented increases in tensile modulus reaching, for instance, 700% for carbon-fiber-reinforced ABS or over 15-fold for continuous aramid composites, enabling their use in functional, load-bearing components. In contrast, the natural ones could even decrease the stiffness and strength (e.g., wood-plastic composites), or, as in the case of flax, significantly increase stiffness (by 88-121%) while offering a sustainable, lightweight alternative for non-structural applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.